Dr Eva Baxter
Dr

Eva Baxter

Email: 
Phone: 
+61 7 334 66049

Background

Dr Baxter is a Senior Research Platform Fellow at the Queensland Centre for Gynaecological Cancer (QCGC) Research and leads its molecular research program. Her research focuses on biomarker discovery and validation to improve clinical outcomes for women with gynaecological cancers. Dr Baxter leads translational studies embedded within QCGC Research’s clinical trials, including the feMMe phase II trial (NCT01686126), which demonstrated that approximately 60% of women with early-stage endometrial cancer can safely avoid hysterectomy through intrauterine progestin therapy. She also leads translational studies for the ongoing ENDO-3 phase III trial (NCT04073706), evaluating the risks and benefits of sentinel node biopsy in early-stage endometrial cancer. Her research bridges molecular science and clinical trials, advancing precision medicine in gynaecological oncology.

Availability

Dr Eva Baxter is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, University of Edinburgh

Research interests

  • Gynaecological cancer

  • Translational research

  • Biomarkers

  • Clinical trials

Search Professor Eva Baxter’s works on UQ eSpace

21 works between 2014 and 2026
All (21) Journal Article (19) Conference Publication (2)

21 - 21 of 21 works

2014

Journal Article

Epigenetic regulation in cancer progression

Baxter, Eva, Windloch, Karolina, Gannon, Frank and Lee, Jason S. (2014). Epigenetic regulation in cancer progression. Cell & Bioscience, 4 (1) 45, 45. doi: 10.1186/2045-3701-4-45

Epigenetic regulation in cancer progression

Current funding

  • 2025 - 2028
    The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
    Cherish Women's Cancer Foundation
    Open grant
  • 2025 - 2030
    Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
    NHMRC Centres of Research Excellence
    Open grant
  • 2024 - 2028
    ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant

Availability

Dr Eva Baxter is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • Improving Quality of Survival for Women with Gynaecological Cancer

    Gynaecological cancers are the third most common cancer type diagnosed in Australian women. Each year over 6,700 Australian women and girls are diagnosed with gynaecological cancer and almost a third will not survive their disease.

    PhD scholarships are available for exceptional students to complete a PhD as part of a National Health and Medical Research Council Centre of Research Excellence (CRE) in Improving the Quality of Survival for Gynaecological Cancer Patients. The aim of this CRE is to address contemporary issues in gynaecological cancer care, with a focus on three priority areas: 1) enabling fertility after endometrial cancer; 2) reducing lymphoedema; and 3) optimising cancer recovery.

    We have three full-time PhD opportunities available focusing on improving quality of life, health, and function during and after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.

Supervision history

Current supervision

Enquiries

Contact Dr Eva Baxter directly for media enquiries about:

  • Biomarkers
  • Endometrial cancer
  • Gynaecological cancer

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au